Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

Statins in the prevention of transplant coronary artery disease: in pediatric heart recipients.

Pahl E.

Pediatr Transplant. 2007 Aug;11(5):459-60. No abstract available.

PMID:
17631010
2.

Coronary risk factor management for the prevention and treatment of graft vessel disease in heart transplant patients.

Jaeger BR, Schirmer J, Thiery J, Meiser BM, Uberfuhr P, Kreuzer E, Reichart B, Seidel D.

Ther Apher. 1999 Aug;3(3):214-8.

PMID:
10427618
3.

Low HDL-C predicts the onset of transplant vasculopathy in pediatric cardiac recipients on pravastatin therapy.

Hedman M, Pahlman R, Sundvall J, Ehnholm C, Syvänne M, Jokinen E, Jauhiainen M, Holmberg C, Antikainen M.

Pediatr Transplant. 2007 Aug;11(5):481-90.

PMID:
17631015
4.

Therapies for raising high-density lipoprotein cholesterol.

Miura S, Saku K.

Intern Med. 2007;46(7):339-40. Epub 2007 Apr 2. No abstract available.

5.
6.
7.

Statins. Cholesterol lowering and beyond.

[No authors listed]

Mayo Clin Womens Healthsource. 2006 Jun;10(6):1-2. No abstract available.

PMID:
16675916
8.

HMG-CoA reductase inhibitors reduce transplant coronary artery disease and mortality: evidence for antigen-independent mechanisms?

Valantine HA, Schroeder JS.

Circulation. 1997 Sep 2;96(5):1370-3. No abstract available.

PMID:
9315517
9.

Vascular disease, hypertension, and prevention.

Lavie CJ.

J Am Coll Cardiol. 2004 Jul 21;44(2 Suppl A):19A-22A. Review. No abstract available.

10.

Statins and cardiac allograft vasculopathy after heart transplantation.

Kobashigawa JA.

Semin Vasc Med. 2004 Nov;4(4):401-6. Review.

PMID:
15861321
11.
12.

Cardiac allograft vasculopathy: prevention and treatment options.

Weis M.

Transplant Proc. 2002 Aug;34(5):1847-9. Review. No abstract available.

PMID:
12176600
13.

[Transplant coronary artery disease--treatment with statins].

Wolszakiewicz J, Bilińska M.

Pol Merkur Lekarski. 2004 May;16(95):472-3. Review. Polish.

PMID:
15518430
14.

High-density lipoprotein cholesterol levels and risk of death in chronic heart failure patients referred for heart transplant evaluation.

Lizak MK, Zakliczynski M, Jarosz A, Zembala M.

J Heart Lung Transplant. 2010 Mar;29(3):386-7. doi: 10.1016/j.healun.2009.08.026. Epub 2009 Oct 28. No abstract available.

PMID:
19864166
15.

Statins, cholesterol, and the prevention of coronary heart disease.

Freeman MW.

FASEB J. 2006 Feb;20(2):200-1. No abstract available.

PMID:
16449790
16.
18.

Statin-associated QTc interval shortening as prognostic indicator in heart transplant recipients.

Vrtovec B, Stojanovic I, Radovancevic R, Yazdanbakhsh AP, Thomas CD, Radovancevic B.

J Heart Lung Transplant. 2006 Feb;25(2):234-6. Epub 2006 Jan 4.

PMID:
16446226
19.

Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.

Alsheikh-Ali AA, Lin JL, Abourjaily P, Ahearn D, Kuvin JT, Karas RH.

Am J Cardiol. 2007 Nov 15;100(10):1499-501. Epub 2007 Sep 27.

PMID:
17996508

Supplemental Content

Support Center